Skip to content

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00398177
Enrollment
9999
Registered
2006-11-10
Start date
1999-01-31
Completion date
2099-01-31
Last updated
2025-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hodgkin's Disease, Lymphoma, Non-Hodgkin

Brief summary

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.

Detailed description

This research involves the study of lymphoma cells in order to better understand how the disease grows and spreads. This study may lead to the development of special materials that could be used, in the future, to treat lymphoma or to follow the response of lymphoma to treatment.

Interventions

None listed

Sponsors

The Leukemia and Lymphoma Society
CollaboratorOTHER
Biospect Inc
CollaboratorINDUSTRY
Stanford University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade. * Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea). * A routine procedure for tissue collection is planned. * Ability to understand and the willingness to sign a written informed consent.

Exclusion criteria

* Patients without NHL or Hodgkin's disease

Design outcomes

Primary

MeasureTime frame
Collection of tumor tissue to characterize the molecular and cell biology of tumor cells in lymphoma.The study will continue indefinitely.

Countries

United States

Contacts

Primary ContactAlyssa M Kanegai
akanegai@stanford.edu650-736-1596

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026